68% of patients felt they had learnt more about their medicines following an MUR, 58% felt they knew more about side effects and 83% thought the MUR improved their compliance.¹
The Medicines Use Review (MUR) and Prescription Intervention Service introduced in 2005 consists of accredited pharmacists undertaking structured adherence-centred reviews with patients on multiple medicines, particularly those receiving medicines for long-term conditions. National target groups are specified to focus the service towards patients of greatest need.
The MUR is usually conducted face to face in the pharmacy and allows an opportunity for the pharmacist to discuss the patient’s prescribed and non-prescribed medicines to increase their knowledge and understanding. It is a chance for any issues with taking the medicines, missing doses, side effects or patient concerns to be raised. The patient is given advice on medicines taking and with the patient’s permission any clinical issues are referred to their GPs.
22nd July 2019 announcement: MURs to be phased out
In 2019/20 contractors can deliver a total of 250 MURs and in 2020/21 this will reduce to 100, with the service being decommissioned at the end of that year. All contractors can provide 250 MURs in total throughout 2019/20, but no more than 200 in the first half of the year. Further information is available on PSNC’s CPCF settlement: 2019/20 to 2023/24 webpage.
Click here to view a set of FAQs relating to this